BUZZ-Australia's Neurizon Therapeutics rises as HY loss narrows, revenue rises
Reuters
Feb 25
BUZZ-Australia's <a href="https://laohu8.com/S/PAAFF">Neurizon Therapeutics</a> rises as HY loss narrows, revenue rises
** Shares of Australia's Neurizon TherapeuticsNUZ.AX rise as much as 3.1% to A$0.1, their highest level since February 19
** Stock on track to record its third straight session of gains, if the trend holds
** Biotech company posts HY loss attributable to A$5.5 million ($3.90 million), compared with a loss of A$7.3 million in the prior corresponding period
** Posts increase in HY revenue to A$6 million from A$1.8 million last year
** Stock has risen 14.1% this year, including session moves
($1 = 1.4120 Australian dollars)
(Reporting by Roshan Thomas in Bengaluru)
((Roshan.Thomas@thomsonreuters.com;))
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.